Prelude was founded in 2016 with one mission -- to help improve the lives of cancer patients. Our pipeline focuses on new approaches to clinically validated targets with transformative potential for patients. We are dedicated to extending the promise of precision medicine to every cancer patient in need.

Prelude is proud to participate in the More than Pink event this year.